Multinational pharmaceutical company and the manufacturer of semaglutide (Ozempic/Wegovy). Operates some of the largest peptide manufacturing facilities in the world.
Novo Nordisk (Peptide Manufacturing) is based in Kalundborg, Denmark, specialising in GLP-1 Agonists, Insulin, Semaglutide, Proprietary Peptides, minimum order Internal / licensed production only.
Licensing on record: Fully licensed pharmaceutical manufacturer. FDA, EMA, and global regulatory approvals..
No independent assay in our records names Novo Nordisk (Peptide Manufacturing) as the manufacturer. Manufacturer attribution only appears where a certificate of analysis records it, so this is common and is not a quality signal in itself.
Manufacturer entries describe who produces a compound, not who sells it to you. For purchasing, the vendor directory records storefront reachability, assay history and FDA warning-letter history separately.
Directories: All manufacturers, Vendor directory, Independent lab tests.